225 related articles for article (PubMed ID: 1677038)
1. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
Grenader A; Healy DP
J Pharmacol Exp Ther; 1991 Jul; 258(1):193-8. PubMed ID: 1677038
[TBL] [Abstract][Full Text] [Related]
2. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.
Hedge SS; Ricci A; Amenta F; Lokhandwala MF
J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam.
Christie MI; Smith GW
J Pharmacol Exp Ther; 1994 Feb; 268(2):565-70. PubMed ID: 7906731
[TBL] [Abstract][Full Text] [Related]
4. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
Clark KL; Hilditch A; Robertson MJ; Drew GM
J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741
[TBL] [Abstract][Full Text] [Related]
5. DA1 dopamine receptors in renal cortical collecting duct.
Ohbu K; Felder RA
Am J Physiol; 1991 Nov; 261(5 Pt 2):F890-5. PubMed ID: 1683170
[TBL] [Abstract][Full Text] [Related]
6. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
Chen CJ; Apparsundaram S; Lokhandwala MF
J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595
[TBL] [Abstract][Full Text] [Related]
7. Locally formed dopamine stimulates cAMP accumulation in LLC-PK1 cells via a DA1 dopamine receptor.
Grenader A; Healy DP
Am J Physiol; 1991 Jun; 260(6 Pt 2):F906-12. PubMed ID: 1647691
[TBL] [Abstract][Full Text] [Related]
8. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I
J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
[TBL] [Abstract][Full Text] [Related]
9. Effects of dopamine receptor agonists on the cAMP content in arteries of the rabbit.
Zhu L; Zhao RR; Zhang WF
Sheng Li Xue Bao; 2000 Jun; 52(3):247-51. PubMed ID: 11956574
[TBL] [Abstract][Full Text] [Related]
10. A68930 is a potent, full agonist at dopamine1 (D1) receptors in renal epithelial LLC-PK1 cells.
Grenader A; Healy DP
Br J Pharmacol; 1992 Jun; 106(2):229-30. PubMed ID: 1356555
[TBL] [Abstract][Full Text] [Related]
11. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
[TBL] [Abstract][Full Text] [Related]
12. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
Bughi S; Horton R; Antonipillai I; Manoogian C; Ehrlich L; Nadler J
J Clin Endocrinol Metab; 1989 Dec; 69(6):1116-21. PubMed ID: 2573613
[TBL] [Abstract][Full Text] [Related]
13. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
[TBL] [Abstract][Full Text] [Related]
14. The pharmacology of fenoldopam.
Nichols AJ; Ruffolo RR; Brooks DP
Am J Hypertens; 1990 Jun; 3(6 Pt 2):116S-119S. PubMed ID: 1974439
[TBL] [Abstract][Full Text] [Related]
15. Dopamine inhibits Na/K-ATPase in single tubules and cultured cells from distal nephron.
Takemoto F; Cohen HT; Satoh T; Katz AI
Pflugers Arch; 1992 Jul; 421(4):302-6. PubMed ID: 1357625
[TBL] [Abstract][Full Text] [Related]
16. Dopamine stimulation of cAMP production in cultured opossum kidney cells.
Cheng L; Precht P; Frank D; Liang CT
Am J Physiol; 1990 Apr; 258(4 Pt 2):F877-82. PubMed ID: 1691897
[TBL] [Abstract][Full Text] [Related]
17. Human vasodilator responses to a dopamine agonist: possible mechanisms.
Redman D; Thom SA; Hughes AD; Hasan S; Sever PS
J Hypertens Suppl; 1985 Dec; 3(3):S177-8. PubMed ID: 2908815
[TBL] [Abstract][Full Text] [Related]
18. Systemic and pulmonary vascular effects of selective dopamine receptor blockade and stimulation in lambs.
Polak MJ; Drummond WH
Pediatr Res; 1993 Feb; 33(2):181-4. PubMed ID: 8094550
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.
Lin CW; Miller TR; Witte DG; Bianchi BR; Stashko M; Manelli AM; Frail DE
Mol Pharmacol; 1995 Jan; 47(1):131-9. PubMed ID: 7838121
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the effects of dopamine-1 and dopamine-2 receptor agonists on coronary flow.
Zhao RR; Wang PH; Zhang WF; Fennell WH
Methods Find Exp Clin Pharmacol; 1992; 14(1):5-11. PubMed ID: 1352371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]